Skip to content

PLx Pharma Winddown Corp.

Delisted

CIK 1497504fmd_0ND8K4MBYKB8R8QH7X325DKDXPManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 14, 2010 to Sep 30, 2022, 42 periods

Latest annual · FY2021

Millions
Total revenues
8
Gross profit
3
Operating income
(41)
Net income
(46)
Free cash flow
(12)

Latest quarter · Q3 FY2022

Millions
Total revenues
0
Gross profit
(1)
Operating income
(11)
Net income
(8)
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2018 to FY2021
+121.7%
Revenue, 5 yearsFY2016 to FY2021
+233.2%
Net income, 5 yearsFY2016 to FY2021
n/m

PLx Pharma Winddown Corp. financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2021FY2020ChangeSource
Revenue$8.2 million$30,000+27,260%10-K 2022-03-11 · proof
Gross profit$3.4 million$30,000+11,243.3%10-K 2022-03-11 · proof
Operating income-$40.8 million-$13.5 million10-K 2022-03-11 · proof
Net income-$46.1 million-$15.2 million10-K 2022-03-11 · proof
Cash from operating activities-$32.1 million-$12.2 million10-K 2022-03-11 · proof
Total assets$76.6 million$26.6 million+187.9%10-K 2022-03-11 · proof
Total liabilities$25 million$16.2 million+54.4%10-K 2022-03-11 · proof
Cash and cash equivalents$69.4 million$22.4 million+209.1%10-K 2022-03-11 · proof
What was PLx Pharma Winddown Corp.'s revenue in fiscal 2021?
PLx Pharma Winddown Corp. reported revenue of $8.2 million for fiscal 2021 (the year ended Dec 31, 2021), against $30,000 the year before (+27,260%). Source: the 10-K filed with the SEC on Mar 11, 2022. SEC
What was PLx Pharma Winddown Corp.'s gross profit in fiscal 2021?
PLx Pharma Winddown Corp. reported gross profit of $3.4 million for fiscal 2021 (the year ended Dec 31, 2021), against $30,000 the year before (+11,243.3%). Source: the 10-K filed with the SEC on Mar 11, 2022. SEC
What was PLx Pharma Winddown Corp.'s operating income in fiscal 2021?
PLx Pharma Winddown Corp. reported operating income of -$40.8 million for fiscal 2021 (the year ended Dec 31, 2021), against -$13.5 million the year before. Source: the 10-K filed with the SEC on Mar 11, 2022. SEC
What was PLx Pharma Winddown Corp.'s net income in fiscal 2021?
PLx Pharma Winddown Corp. reported net income of -$46.1 million for fiscal 2021 (the year ended Dec 31, 2021), against -$15.2 million the year before. Source: the 10-K filed with the SEC on Mar 11, 2022. SEC
What was PLx Pharma Winddown Corp.'s cash from operating activities in fiscal 2021?
PLx Pharma Winddown Corp. reported cash from operating activities of -$32.1 million for fiscal 2021 (the year ended Dec 31, 2021), against -$12.2 million the year before. Source: the 10-K filed with the SEC on Mar 11, 2022. SEC
What are PLx Pharma Winddown Corp.'s total assets?
As of Dec 31, 2021, PLx Pharma Winddown Corp. reported total assets of $76.6 million, against $26.6 million a year earlier (+187.9%). Source: the 10-K filed with the SEC on Mar 11, 2022. SEC
What are PLx Pharma Winddown Corp.'s total liabilities?
As of Dec 31, 2021, PLx Pharma Winddown Corp. reported total liabilities of $25 million, against $16.2 million a year earlier (+54.4%). Source: the 10-K filed with the SEC on Mar 11, 2022. SEC
What are PLx Pharma Winddown Corp.'s cash and cash equivalents?
As of Dec 31, 2021, PLx Pharma Winddown Corp. reported cash and cash equivalents of $69.4 million, against $22.4 million a year earlier (+209.1%). Source: the 10-K filed with the SEC on Mar 11, 2022. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1497504&period_type=annual&limit=5"

Information only, not investment advice.